BAX
Price
$29.50
Change
+$0.60 (+2.08%)
Updated
Dec 20 closing price
38 days until earnings call
MDT
Price
$81.03
Change
+$1.04 (+1.30%)
Updated
Dec 20 closing price
57 days until earnings call
Ad is loading...

BAX vs MDT

Header iconBAX vs MDT Comparison
Open Charts BAX vs MDTBanner chart's image
Baxter International
Price$29.50
Change+$0.60 (+2.08%)
Volume$12.19M
CapitalizationN/A
Medtronic
Price$81.03
Change+$1.04 (+1.30%)
Volume$10.71M
CapitalizationN/A
BAX vs MDT Comparison Chart
Loading...
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BAX vs. MDT commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAX is a Hold and MDT is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (BAX: $29.50 vs. MDT: $81.03)
Brand notoriety: BAX: Not notable vs. MDT: Notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BAX: 285% vs. MDT: 170%
Market capitalization -- BAX: $21.77B vs. MDT: $115.55B
BAX [@Medical Specialties] is valued at $21.77B. MDT’s [@Medical Specialties] market capitalization is $115.55B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BAX’s FA Score shows that 2 FA rating(s) are green whileMDT’s FA Score has 1 green FA rating(s).

  • BAX’s FA Score: 2 green, 3 red.
  • MDT’s FA Score: 1 green, 4 red.
According to our system of comparison, BAX is a better buy in the long-term than MDT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BAX’s TA Score shows that 4 TA indicator(s) are bullish while MDT’s TA Score has 4 bullish TA indicator(s).

  • BAX’s TA Score: 4 bullish, 4 bearish.
  • MDT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BAX is a better buy in the short-term than MDT.

Price Growth

BAX (@Medical Specialties) experienced а -2.70% price change this week, while MDT (@Medical Specialties) price change was -1.76% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.51%. For the same industry, the average monthly price growth was +1.92%, and the average quarterly price growth was +0.64%.

Reported Earning Dates

BAX is expected to report earnings on Jan 30, 2025.

MDT is expected to report earnings on Feb 18, 2025.

Industries' Descriptions

@Medical Specialties (-1.51% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDT($116B) has a higher market cap than BAX($21.8B). BAX has higher P/E ratio than MDT: BAX (85.61) vs MDT (27.63). MDT YTD gains are higher at: 0.848 vs. BAX (-21.491). MDT has higher annual earnings (EBITDA): 8.91B vs. BAX (1.67B). MDT has more cash in the bank: 8.32B vs. BAX (3.19B). BAX has less debt than MDT: BAX (14.4B) vs MDT (25.2B). MDT has higher revenues than BAX: MDT (32.3B) vs BAX (14.8B).
BAXMDTBAX / MDT
Capitalization21.8B116B19%
EBITDA1.67B8.91B19%
Gain YTD-21.4910.848-2,535%
P/E Ratio85.6127.63310%
Revenue14.8B32.3B46%
Total Cash3.19B8.32B38%
Total Debt14.4B25.2B57%
FUNDAMENTALS RATINGS
BAX vs MDT: Fundamental Ratings
BAX
MDT
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
4
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8975
PRICE GROWTH RATING
1..100
6458
P/E GROWTH RATING
1..100
2268
SEASONALITY SCORE
1..100
5095

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MDT's Valuation (4) in the Medical Specialties industry is in the same range as BAX (5). This means that MDT’s stock grew similarly to BAX’s over the last 12 months.

MDT's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as BAX (100). This means that MDT’s stock grew similarly to BAX’s over the last 12 months.

MDT's SMR Rating (75) in the Medical Specialties industry is in the same range as BAX (89). This means that MDT’s stock grew similarly to BAX’s over the last 12 months.

MDT's Price Growth Rating (58) in the Medical Specialties industry is in the same range as BAX (64). This means that MDT’s stock grew similarly to BAX’s over the last 12 months.

BAX's P/E Growth Rating (22) in the Medical Specialties industry is somewhat better than the same rating for MDT (68). This means that BAX’s stock grew somewhat faster than MDT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BAXMDT
RSI
ODDS (%)
Bullish Trend 3 days ago
57%
Bullish Trend 3 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
59%
Bullish Trend 3 days ago
55%
Momentum
ODDS (%)
Bearish Trend 3 days ago
62%
Bearish Trend 3 days ago
56%
MACD
ODDS (%)
Bearish Trend 3 days ago
69%
Bearish Trend 3 days ago
65%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
62%
Bearish Trend 3 days ago
52%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
64%
Bearish Trend 3 days ago
53%
Advances
ODDS (%)
Bullish Trend 24 days ago
51%
Bullish Trend 24 days ago
48%
Declines
ODDS (%)
Bearish Trend 4 days ago
58%
Bearish Trend 4 days ago
54%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
64%
Bullish Trend 3 days ago
63%
Aroon
ODDS (%)
Bearish Trend 3 days ago
60%
Bearish Trend 3 days ago
55%
View a ticker or compare two or three
Ad is loading...
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SWTX35.590.81
+2.33%
SpringWorks Therapeutics
CRNC7.670.09
+1.19%
Cerence
RNR249.371.00
+0.40%
RenaissanceRe Holdings Ltd
OPAL2.99-0.02
-0.66%
OPAL Fuels
GDC1.85-0.05
-2.63%
GD Culture Group Limited